Severe Airway Injury Due to Alendronate Aspiration
Author(s) -
Paul MacEachern,
Aiden Brazil,
Alain Tremblay,
David R. Stather,
Alex Chee,
Julie Chou
Publication year - 2013
Publication title -
canadian respiratory journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.675
H-Index - 53
eISSN - 1916-7245
pISSN - 1198-2241
DOI - 10.1155/2013/753906
Subject(s) - medicine , airway , intubation , asymptomatic , foreign body aspiration , bisphosphonate , adverse effect , esophagitis , pulmonary aspiration , bronchoscopy , surgery , anesthesia , osteoporosis , disease , reflux
Sequelae of foreign body aspiration can range from clinically silent and asymptomatic to immediate asphyxiation and death. Only two previous cases of bisphosphonate tablet aspiration have been reported. Ulcerative esophagitis, a known adverse effect of oral bisphosphonate formulations, occurs primarily with prolonged exposure of esophageal mucosa to the medication. Little is known about the effects of bisphosphonates on the airway mucosa. The authors present a case involving an 84-year-old woman who required multiple bronchoscopic debridements, intubation for airway protection and intensive care unit admission following airway injury believed to be due to delayed recognition of aspiration of an alendronate tablet.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom